The PHQ-9: validity of a brief depression severity measure.
Journal: 2001/October - Journal of General Internal Medicine
ISSN: 0884-8734
PUBMED: 11556941
Abstract:
OBJECTIVE
While considerable attention has focused on improving the detection of depression, assessment of severity is also important in guiding treatment decisions. Therefore, we examined the validity of a brief, new measure of depression severity.
METHODS
The Patient Health Questionnaire (PHQ) is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders. The PHQ-9 is the depression module, which scores each of the 9 DSM-IV criteria as "0" (not at all) to "3" (nearly every day). The PHQ-9 was completed by 6,000 patients in 8 primary care clinics and 7 obstetrics-gynecology clinics. Construct validity was assessed using the 20-item Short-Form General Health Survey, self-reported sick days and clinic visits, and symptom-related difficulty. Criterion validity was assessed against an independent structured mental health professional (MHP) interview in a sample of 580 patients.
RESULTS
As PHQ-9 depression severity increased, there was a substantial decrease in functional status on all 6 SF-20 subscales. Also, symptom-related difficulty, sick days, and health care utilization increased. Using the MHP reinterview as the criterion standard, a PHQ-9 score>> or =10 had a sensitivity of 88% and a specificity of 88% for major depression. PHQ-9 scores of 5, 10, 15, and 20 represented mild, moderate, moderately severe, and severe depression, respectively. Results were similar in the primary care and obstetrics-gynecology samples.
CONCLUSIONS
In addition to making criteria-based diagnoses of depressive disorders, the PHQ-9 is also a reliable and valid measure of depression severity. These characteristics plus its brevity make the PHQ-9 a useful clinical and research tool.
Relations:
Content
Citations
(3K+)
References
(22)
Clinical trials
(81)
Diseases
(1)
Organisms
(1)
Similar articles
Articles by the same authors
Discussion board
J Gen Intern Med 16(9): 606-613

The PHQ-9

Received from the Regenstrief Institute for Health Care and Department of Medicine, Indiana University, Indianapolis, Ind
The New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York, NY
Address correspondence and reprint requests to Dr. Kroenke: Regenstrief Institute for Health Care, RG-6, 1050 Wishard Blvd., Indianapolis, IN 46202 (e-mail: gro.feirtsneger@ekneorkk).

Abstract

OBJECTIVE

While considerable attention has focused on improving the detection of depression, assessment of severity is also important in guiding treatment decisions. Therefore, we examined the validity of a brief, new measure of depression severity.

MEASUREMENTS

The Patient Health Questionnaire (PHQ) is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders. The PHQ-9 is the depression module, which scores each of the 9 DSM-IV criteria as “0” (not at all) to “3” (nearly every day). The PHQ-9 was completed by 6,000 patients in 8 primary care clinics and 7 obstetrics-gynecology clinics. Construct validity was assessed using the 20-item Short-Form General Health Survey, self-reported sick days and clinic visits, and symptom-related difficulty. Criterion validity was assessed against an independent structured mental health professional (MHP) interview in a sample of 580 patients.

RESULTS

As PHQ-9 depression severity increased, there was a substantial decrease in functional status on all 6 SF-20 subscales. Also, symptom-related difficulty, sick days, and health care utilization increased. Using the MHP reinterview as the criterion standard, a PHQ-9 score ≥10 had a sensitivity of 88% and a specificity of 88% for major depression. PHQ-9 scores of 5, 10, 15, and 20 represented mild, moderate, moderately severe, and severe depression, respectively. Results were similar in the primary care and obstetrics-gynecology samples.

CONCLUSION

In addition to making criteria-based diagnoses of depressive disorders, the PHQ-9 is also a reliable and valid measure of depression severity. These characteristics plus its brevity make the PHQ-9 a useful clinical and research tool.

Keywords: depression, diagnosis, screening, psychological tests, health status
Abstract

Depression is one of the most prevalent and treatable mental disorders and is regularly seen by a wide spectrum of health care providers, including mental health specialists, medical and surgical subspecialists, and primary care clinicians. There are a number of case-finding instruments for detecting depression in primary care, ranging from 2 to 28 items in length.12 Typically, these can be scored as continuous measures of depression severity and also have established cut points above which the probability of major depression is substantially increased. Scores on these various measures tend to be highly correlated,3 and it is not evident that any one measure is superior to the others.124

The Patient Health Questionnaire (PHQ) is a new instrument for making criteria-based diagnoses of depressive and other mental disorders commonly encountered in primary care. The diagnostic validity of the PHQ has recently been established in 2 studies involving 3,000 patients in 8 primary care clinics and 3,000 patients in 7 obstetrics-gynecology clinics.56 At 9 items, the PHQ depression scale (which we call the PHQ-9) is half the length of many other depression measures, has comparable sensitivity and specificity, and consists of the actual 9 criteria upon which the diagnosis of DSM-IV depressive disorders is based. The latter feature distinguishes the PHQ-9 from other “2-step” depression measures for which, when scores are high, additional questions must be asked to establish DSM-IV depressive diagnoses. The PHQ-9 has the potential of being a dual-purpose instrument that, with the same 9 items, can establish depressive disorder diagnoses as well as grade depressive symptom severity. In this paper, we analyze data regarding the PHQ-9 to address 3 major questions:

  1. What is the reliability and efficiency of the PHQ-9 in clinical practice?

  2. What are the operating characteristics (sensitivity and specificity) of the PHQ-9 as a diagnostic instrument for depressive disorders?

  3. What is the construct validity of the PHQ-9 as a depression severity measure in relation to functional status, disability days, and health care utilization?

Most pairwise comparisons of mean SF-20 scores between each PHQ-9 level within each scale are significant at P < 0.05 using Bonferroni's correction for multiple comparisons. Only those pairwise comparisons that share a common superscript letter (a, b, or a,b) are not significant.

Most pairwise comparisons between each PHQ-9 severity level for a given variable are significant at P < 0.05 using Bonferroni's correction for multiple comparisons. Only those pairwise comparisons that share a common superscript letter (a, b, or a,b) are not significant.

Acknowledgments

The development of the PHQ-9 was underwritten by an educational grant from Pfizer US Pharmaceuticals, New York, NY. PRIME-MD is a trademark of Pfizer Copyright held by Pfizer.

Acknowledgments

REFERENCES

REFERENCES

References

  • 1. Mulrow CD, Williams JW, Gerety MB, Ramirez G, Montiel OM, Kerber CCase-finding instruments for depression in primary care settings. Ann Intern Med. 1995;122:913–21.[PubMed][Google Scholar]
  • 2. Whooley MA, Avins AL, Miranda J, Browner WSCase-finding instruments for depression: two questions are as good as many. J Gen Intern Med. 1997;12:439–45.[Google Scholar]
  • 3. Keller MB, Kocsis JH, Thase ME, et al Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA. 1998;280:1665–72.[PubMed][Google Scholar]
  • 4. McDowell I, Kristjansson E, Newell C. Depression. In: McDowell I, Newell C, editors. Measuring Health: A Guide to Rating Scales and Questionnaires. 2nd ed. New York, NY: Oxford University Press; 1996. pp. 238–86. [PubMed]
  • 5. Spitzer RL, Kroenke K, Williams JBW. Patient Health Questionnaire Study Group. Validity and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study. JAMA. 1999;282:1737–44.[PubMed]
  • 6. Spitzer RL, Williams JBW, Kroenke K, et al Validity and utility of the Patient Health Questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study. Am J Obstet Gynecol. 2000;183:759–69.[PubMed][Google Scholar]
  • 7. Stewart AL, Hays RD, Ware JEThe MOS Short-Form General Health Survey: reliability and validity in a patient population. Med Care. 1988;26:724–32.[PubMed][Google Scholar]
  • 8. Spitzer RL, Williams JBW, Gibbon M, First MBThe structured clinical interview for DSM-III-R (SCID). Arch Gen Psychiatry. 1992;49:624–9.[PubMed][Google Scholar]
  • 9. Spitzer RL, Williams JBW, Kroenke K, et al Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA. 1994;272:1749–56.[PubMed][Google Scholar]
  • 10. Sackett DL, Haynes RB, Guyatt GH, Tugwell P Clinical Epidemiology: A Basic Science for Clinical Medicine. 2nd ed. Boston, MA: Little, Brown and Company; 1991. pp. 1–441. [PubMed][Google Scholar]
  • 11. Murphy JM, Berwick DM, Weinstein MC, et al Performance of screening and diagnostic tests: application of receiver operating characteristic analysis. Arch Gen Psychiatry. 1987;44:550–5.[PubMed][Google Scholar]
  • 12. Pasacreta JV. Measuring depression. In: Frank-Stromborg M, Olsen SJ, editors. Instruments for Clinical Health-Care Research. 2nd Ed. Sudbury, MA: Jones and Bartlett Publishers; 1997. pp. 342–630. [PubMed]
  • 13. Kazis LE, Anderson JJ, Meenan RFEffect sizes for interpreting changes in health status. Med Care. 1989;27:S178–89.[PubMed][Google Scholar]
  • 14. Berwick DM, Murphy JM, Goldman PA, Ware JE, Barsky AJ, Weinstein MCPerformance of a five-item mental health screening test. Med Care. 1991;29:169–76.[PubMed][Google Scholar]
  • 15. Montgomery SA, Asberg MA new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–9.[PubMed][Google Scholar]
  • 16. Davidson J, Turnbull CD, Strickland R, et al The Montgomery-Asberg Depression Scale: reliability and validity. Acta Psychiatr Scand. 1986;73:544–8.[PubMed][Google Scholar]
  • 17. Lambert MJ, Hatch DR, Kingston MD, et al Zung, Beck, and Hamilton rating scales as measures of treatment outcome: a meta-analytic comparison. J Consult Clin Psychol. 1986;54:54–9.[PubMed][Google Scholar]
  • 18. Katon W, Robinson P, Von Korff M, et al A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 1996;53:924–32.[PubMed][Google Scholar]
  • 19. Katon W, Von Korff M, Lin E, et al Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA. 1995;273:1026–31.[PubMed][Google Scholar]
  • 20. Williams JW, Barrett J, Oxman T, et al Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults. JAMA. 2000;284:1519–26.[PubMed][Google Scholar]
  • 21. Kroenke K, Taylor-Vaisey A, Dietrich AJ, Oxman TEInterventions to improve provider diagnosis and treatment of mental disorders in primary care: a critical review of the literature. Psychosomatics. 2000;41:39–52.[PubMed][Google Scholar]
  • 22. Simon GECan depression be managed appropriately in primary care? J Clin Psychiatry. 1998;59(suppl 2):3–8.[PubMed][Google Scholar]
  • 23. Hunkeler EM, Meresman J, Hargreaves WA, et al Efficacy of nurse telehealth care and peer support in augmenting treatment of depression in primary care. Arch Fam Med. 2000;9:700–8.[PubMed][Google Scholar]
  • 24. Kobak KA, Taylor LH, Dottl SL, et al A computer-administered telephone interview to identify mental disorders. JAMA. 1997;278:905–10.[PubMed][Google Scholar]
  • 25. Williams JW, Mulrow CD, Kroenke K, et al Case-finding for depression improves patient outcomes: results from a randomized trial in primary care. Am J Med. 1999;106:36–43.[PubMed][Google Scholar]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.